Table 3.
3-year survival | 6-year survival | |||
---|---|---|---|---|
Sensitivity (95% CI) in % | Specificity (95% CI) in % | Sensitivity (95% CI) in % | Specificity (95% CI) in % | |
Men (n = 513) | ||||
EWGSOP2 low grip strength cut-off point | 32.7 (20.2, 45.4) | 87.9 (85.3, 90.3) | 30.1 (22.5, 37.2) | 90.8 (88.0, 93.1) |
NAKO-derived low grip strength cut-off point | 51.9 (38.7, 63.1) | 80.9 (78.0, 84.5) | 45.5 (35.6, 52.4) | 84.9 (81.1, 87.9) |
Difference (EWGSOP2 - NAKO-derived cut-off point) | -19.2 (-29.9, -8.5) | 6.9 (4.6, 9.3) | -15.4 (-21.8, -9.1) | 5.9 (3.6, 8.2) |
Women (n = 499) | ||||
EWGSOP2 low grip strength cut-off point | 37.5 (22.5, 53.0) | 88.0 (84.7, 90.9) | 27.3 (18.9, 40.6) | 88.9 (85.3, 91.6) |
NAKO-derived low grip strength cut-off point | 54.2 (37.1, 72.1) | 82.9 (79.4, 86.2) | 36.4 (28.2, 52.6) | 83.8 (80.2, 87.4) |
Difference (EWGSOP2 - NAKO-derived cut-off point) | -16.7 (-31.6, -1.8) | 5.1 (3.1, 7.0) | -9.1 (-16, -2.2) | 5.1 (3.0, 7.1) |
CI: confidence interval, EWGSOP2: European Working Group on Sarcopenia in Older People 2, n: number of participants, NAKO: German National Cohort.